- Home
- MREO vs PMO Comparison
MREO vs PMO Comparison
Compare MREO & PMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- PMO
- Stock Information
- Founded
- MREO 2015
- PMO 1993
- Country
- MREO United Kingdom
- PMO United States
- Employees
- MREO N/A
- PMO N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- PMO Finance Companies
- Sector
- MREO Health Care
- PMO Finance
- Exchange
- MREO Nasdaq
- PMO Nasdaq
- Market Cap
- MREO 369.2M
- PMO 308.4M
- IPO Year
- MREO N/A
- PMO N/A
- Fundamental
- Price
- MREO $2.26
- PMO $10.18
- Analyst Decision
- MREO Strong Buy
- PMO
- Analyst Count
- MREO 7
- PMO 0
- Target Price
- MREO $7.71
- PMO N/A
- AVG Volume (30 Days)
- MREO 1.2M
- PMO 99.0K
- Earning Date
- MREO 03-26-2025
- PMO 01-01-0001
- Dividend Yield
- MREO N/A
- PMO 4.10%
- EPS Growth
- MREO N/A
- PMO N/A
- EPS
- MREO N/A
- PMO 0.42
- Revenue
- MREO N/A
- PMO N/A
- Revenue This Year
- MREO N/A
- PMO N/A
- Revenue Next Year
- MREO $69.09
- PMO N/A
- P/E Ratio
- MREO N/A
- PMO $24.38
- Revenue Growth
- MREO N/A
- PMO N/A
- 52 Week Low
- MREO $2.16
- PMO $8.57
- 52 Week High
- MREO $5.02
- PMO $10.68
- Technical
- Relative Strength Index (RSI)
- MREO 33.19
- PMO 35.21
- Support Level
- MREO $2.23
- PMO $10.10
- Resistance Level
- MREO $2.73
- PMO $10.43
- Average True Range (ATR)
- MREO 0.14
- PMO 0.10
- MACD
- MREO -0.01
- PMO -0.02
- Stochastic Oscillator
- MREO 7.89
- PMO 22.86
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About PMO Putnam Municipal Opportunities Trust
Putnam Municipal Opportunities Trust is a non-diversified closed-end management investment company. It seeks to provide as high a level of current income free from federal income tax as Putnam Management believes is consistent with the preservation of capital. The fund invests in healthcare, utilities, transportation, tax bonds, local debt, state debt, and education.